Gavin Maxwell

2.6k citations

51 papers · 1.3k indexed · h-index 21

Impact in

Dermatology top 0.5%
- Contact Dermatitis and Allergies
Small Animals top 1%
- Animal testing and alternatives

Papers in ⓘ

Dermatology 26
- Contact Dermatitis and Allergies 26
Small Animals 19
- Animal testing and alternatives 19

Co-authors: Ian Kimber (11 shared papers)David A. Basketter (6 shared papers)Rebecca J. Dearman (10 shared papers)Cameron MacKay (7 shared papers)N. Gilmour (9 shared papers)Marie Cumberbatch (3 shared papers)Carl Westmoreland (6 shared papers)Jason Williams (6 shared papers)
Journals: Regulatory Toxicology and Pharmacology (8 papers)Alternatives to Laboratory Animals (6 papers)Contact Dermatitis (4 papers)Toxicology in Vitro (3 papers)Toxicology (2 papers)
Partner nations: United Kingdom Germany Italy

In The Last Decade

Gavin Maxwell

47 papers receiving 1.2k citations

Peers

Countries citing papers authored by Gavin Maxwell

Since Specialization

Citations

This map shows the geographic impact of Gavin Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Maxwell more than expected).

Fields of papers citing papers by Gavin Maxwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Maxwell. The network helps show where Gavin Maxwell may publish in the future.

Co-authors

The 25 scholars most cited alongside Gavin Maxwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gavin Maxwell Line = papers co-authored together Gavin Maxwell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Categorization of Chemicals According to Their Relative Human Skin Sensitizing Potency Dermatitis ·David A. Basketter, Nathalie Alépée, Takao Ashikaga, José G. Barroso, N. Gilmour, Carsten Goebel, Jalila Hibatallah, Sebastian Hoffmann, Petra Kern, Silvia Martinozzi-Teissier, Gavin Maxwell, Kerstin Reisinger, Hitoshi Sakaguchi, Andreas Schepky, Magalie Tailhardat, Marie Templier	2014	157
2	How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology Toxicological Sciences ·Clemens Wittwehr, Hristo Aladjov, Gerald T. Ankley, Hugh J. Byrne, Joop de Knecht, Elmar Heinzle, Günter Klambauer, Brigitte Landesmann, Mirjam Luijten, Cameron MacKay, Gavin Maxwell, M.E. Meek, Alicia Paini, Edward J. Perkins, Tomasz Sobański, Dan Villeneuve, Katrina M. Waters, Maurice Whelan	2016	119
3	The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model International Immunology ·Toshiki Tamura, Haruyuki Ariga, Tatsuo Kinashi, Shuichiro Uehara, Takeshi Kikuchi, Makiyo Nakada, Takeshi Tokunaga, Wen Xu, Ai Kariyone, Takashi Saito, Toshio Kitamura, Gavin Maxwell, Satoshi Takaki, Kiyoshi Takatsu	2004	99
4	Toll‐like receptor ligand activation of murine bone marrow‐derived dendritic cells Immunology ·Rebecca J. Dearman, Marie Cumberbatch, Gavin Maxwell, David A. Basketter, Ian Kimber	2008	87
5	Quantitative Characterization of the T Cell Receptor Repertoire of Naïve and Memory Subsets Using an Integrated Experimental and Computational Pipeline Which Is Robust, Economical, and Versatile Frontiers in Immunology ·Theres Oakes, James Heather, Katharine Best, Rachel Byng-Maddick, Connor Husovsky, Mazlina Ismail, Kroopa Joshi, Gavin Maxwell, Mahdad Noursadeghi, Natalie E. Riddell, Tabea Ruehl, Carolin T. Turner, Imran Uddin, Benny Chain	2017	68
6	Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive Workshop Regulatory Toxicology and Pharmacology ·Carl Westmoreland, Hans Bender, John E. Doe, Miriam N. Jacobs, George E.N. Kass, Federica Madia, Catherine Mahony, Irene Manou, Gavin Maxwell, Pilar Prieto, R Roggeband, Tomasz Sobański, Katrin Schütte, Andrew Worth, Zvonimir Zvonar, M Cronin	2022	68
7	Identifying and characterizing chemical skin sensitizers without animal testing: Colipa’s research and method development program Toxicology in Vitro ·Pierre Aeby, Takao Ashikaga, S. Bessou‐Touya, Andreas Schepky, Frank Gerberick, Petra Kern, Monique Marrec-Fairley, Gavin Maxwell, J.‐M. Ovigne, H. Sakaguchi, Kerstin Reisinger, Magalie Tailhardat, Silvia Martinozzi-Teissier, Petra Winkler	2010	56
8	Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment Toxicology in Vitro ·Gavin Maxwell, Cameron MacKay, Richard Cubberley, Michael J. Davies, Nichola Gellatly, Stephen Glavin, Todd Gouin, Sandrine Jacquoilleot, Craig S. Moore, Ruth Pendlington, Ouarda Saib, David Sheffield, Richard Stark, Vicki Summerfield	2013	54
9	Allergic contact dermatitis: A commentary on the relationship between T lymphocytes and skin sensitising potency Toxicology ·Ian Kimber, Gavin Maxwell, Nicky Gilmour, Rebecca J. Dearman, Peter S. Friedmann, Stefan F. Martin	2011	39
10	Upholding the EU's Commitment to ‘Animal Testing as a Last Resort' Under REACH Requires a Paradigm Shift in How We Assess Chemical Safety to Close the Gap Between Regulatory Testing and Modern Safety Science Alternatives to Laboratory Animals ·Julia H. Fentem, Ian Malcomber, Gavin Maxwell, Carl Westmoreland	2021	34
11	Selection of Chemicals for the Development and Evaluation of In Vitro Methods for Skin Sensitisation Testing Alternatives to Laboratory Animals ·Silvia Casati, Pierre Aeby, Ian Kimber, Gavin Maxwell, Jean Marc Ovigne, Erwin Roggen, Costanza Rovida, Luca Tosti, David A. Basketter	2009	33
12	Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment ALTEX ·Gavin Maxwell	2011	33
13	Skin sensitisation – Moving forward with non-animal testing strategies for regulatory purposes in the EU Regulatory Toxicology and Pharmacology ·David Basketter, Nathalie Alépée, Silvia Casati, Jonathan Crozier, Dorothea Eigler, Peter Griem, Bruno Hubesch, Joop de Knecht, Robert Landsiedel, Kimmo Louekari, Irene Manou, Gavin Maxwell, Annette Mehling, Tatiana I. Netzeva, Thomas Petry, Laura Rossi	2013	32
14	Next generation risk assessment for skin allergy: Decision making using new approach methodologies Regulatory Toxicology and Pharmacology ·N. Gilmour, Jack Reynolds, Katarzyna R. Przybylak, Maja Aleksić, N. Aptula, Maria Teresa Baltazar, Richard Cubberley, Ramya Rajagopal, G. Reynolds, Sandrine Spriggs, Charlotte Thorpe, S. Windebank, Gavin Maxwell	2022	27
15	The lymphocyte transformation test in allergic contact dermatitis: New opportunities Journal of Immunotoxicology ·Amy Popple, Jason Williams, Gavin Maxwell, Nichola Gellatly, Rebecca J. Dearman, Ian Kimber	2015	26
16	Application of a Systems Biology Approach to Skin Allergy Risk Assessment Alternatives to Laboratory Animals ·Gavin Maxwell, Cameron MacKay	2008	26
17	Skin sensitization: Uncertainties, challenges, and opportunities for improved risk assessment Contact Dermatitis ·N. Gilmour, Ian Kimber, Jason Williams, Gavin Maxwell	2018	24
18	Probabilistic prediction of human skin sensitiser potency for use in next generation risk assessment Computational Toxicology ·Joe Reynolds, Cameron MacKay, N. Gilmour, David Miguel-Vilumbrales, Gavin Maxwell	2018	23
19	Overcoming Barriers to Validation of Non-animal Partial Replacement Methods/Integrated Testing Strategies: The Report of an EPAA–ECVAM Workshop Alternatives to Laboratory Animals ·Agnieszka Kinsner‐Ovaskainen, Zerrin Akkan, Silvia Casati, Sandra Coecke, Raffaella Corvi, Gianni Dal Negro, Jack de Bruijn, Odile de Silva, Laura Gribaldo, Claudius Griesinger, Joanna Jaworska, Kreysa Joachim, Gavin Maxwell, Pauline McNamee, Anna Price, Pilar Prieto, Roland Schubert, Luca Tosti, Andrew Worth, Valérie Zuang	2009	22
20	Assuring Consumer Safety without Animal Testing: A Feasibility Case Study for Skin Sensitisation Alternatives to Laboratory Animals ·Gavin Maxwell, Maja Aleksić, Aynur O. Aptula, Paul L. Carmichael, Julia H. Fentem, N. Gilmour, Cameron MacKay, Camilla Pease, Ruth Pendlington, Fiona Reynolds, Daniel J. Scott, Guy Warner, Carl Westmoreland	2008	21

About Gavin Maxwell

Gavin Maxwell is a scholar working on Dermatology, Small Animals, Immunology and Allergy, Immunology and Health, Toxicology and Mutagenesis, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include Contact Dermatitis and Allergies (26 papers), Animal testing and alternatives (19 papers), Allergic Rhinitis and Sensitization (12 papers), Effects and risks of endocrine disrupting chemicals (7 papers), Occupational exposure and asthma (6 papers), Agricultural safety and regulations (6 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Dermatology (530 citations), Small Animals (337 citations), Chemical Health and Safety (25 citations), Immunology and Allergy (152 citations) and Immunology (343 citations). Gavin Maxwell has collaborated with scholars based in United Kingdom, Germany and Italy. Frequent co-authors include Ian Kimber, David A. Basketter, Rebecca J. Dearman, Cameron MacKay, N. Gilmour, Marie Cumberbatch, Carl Westmoreland, Jason Williams, Takao Ashikaga and Silvia Martinozzi-Teissier. Their work appears in journals such as Regulatory Toxicology and Pharmacology, Alternatives to Laboratory Animals, Contact Dermatitis, Toxicology in Vitro and Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact